Market Segmentation
- U.S. CRISPR & Cas Genes Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
- By Product
- Kits & Enzymes
- Vector-based Cas
- DNA-free Cas
- Libraries
- Design Tool
- Antibodies
- Others
- Kits & Enzymes
- By Service
- Cell Line Engineering
- gRNA Design
- Microbial Gene Editing
- DNA synthesis
- By Product
- U.S. CRISPR & Cas Genes Application Outlook (Revenue, USD Million, 2018 - 2030)
- Biomedical
- Genome Engineering
- Disease Model Studies
- Functional Genomics
- Epigenetics
- Others
- Agricultural
- Biomedical
- U.S. CRISPR & Cas Genes End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology & Pharmaceutical Companies
- Academics & Government Research Institutes
- Contract Research Organizations (CROs)
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Country market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Country market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
